Situation: A 45-year-old woman comes to the emergency room (ER) with sudden shortness of breath and right-sided pleuritic chest pain that began 2 hours ago, the day after a 14-hour bus trip. She takes a combined estrogen–progestin oral contraceptive. Her right calf is swollen and tender. She weighs 70 kg and has no known drug allergies. Computed tomography pulmonary angiography confirms pulmonary embolism. After a bolus dose, the provider orders unfractionated heparin by continuous intravenous infusion at 18 units/kg/h. The premixed bag contains 25,000 units of heparin in 500 mL. At how many mL/h should the nurse set the infusion pump? Round off to the nearest tenth.

The hourly dose is 70 kg × 18 units/kg/h = 1,260 units/h. The concentration is 25,000 units ÷ 500 mL = 50 units/mL, so the rate is 1,260 ÷ 50 = 25.2 mL/h. Heparin is a high-alert drug, so the rate is independently double-checked by a second nurse and given by infusion pump.

The calculation begins with determining the hourly heparin dose based on body weight. The patient weighs 70 kg, and the prescribed rate is 18 units/kg/h. Multiplying these gives 1,260 units/h. The premixed bag contains 25,000 units in 500 mL, which yields a concentration of 50 units/mL. Dividing the hourly dose by the concentration (1,260 ÷ 50) produces an infusion rate of 25.2 mL/h.

Why weight-based dosing matters

Unfractionated heparin binds to plasma proteins, endothelial cells, and macrophages, which creates significant interpatient variability in anticoagulant response. Weight-based dosing reduces this variability because heparin distribution is closely tied to blood volume, which correlates with lean body mass. A fixed dose would under-anticoagulate larger patients and over-anticoagulate smaller ones. In the patient described here, the clinical presentation—sudden dyspnea, pleuritic chest pain, unilateral calf swelling, and a history of prolonged immobility plus combined oral contraceptive use—places her at high risk for a large thrombus burden. A precise weight-adjusted infusion is the first step toward rapidly achieving a therapeutic activated partial thromboplastin time (aPTT).

High-alert medication safeguards

Heparin is classified as a high-alert medication because dosing errors can cause catastrophic bleeding or recurrent thrombosis. The infusion rate must be independently double-checked by a second nurse before the pump is started, and the pump itself must be programmed using the calculated mL/h rate rather than units/h. The electronic health record (EHR) can support this process. In one emergency department quality-improvement report, integrating a heparin calculator into the EHR reduced variability in initial infusion rates and served as a risk-mitigation strategy for this high-risk drug ^[1]. The calculator performed the same arithmetic shown above, but automated it so that the nurse only needed to confirm the weight and the ordered units/kg/h.

Concentration and pump programming

The premixed bag concentration of 50 units/mL is standard in many institutions because it simplifies mental math and reduces the chance of a tenfold error. Watch out! If the nurse mistakenly programs 1,260 mL/h instead of 25.2 mL/h, the patient would receive 63,000 units/h—a massive overdose. The double-check must verify both the arithmetic and the pump setting against the original order.

Monitoring after the bolus and infusion start

The bolus dose rapidly achieves a therapeutic heparin concentration, while the continuous infusion maintains it. The aPTT is typically measured 6 hours after the infusion begins to assess whether the rate needs adjustment. Early studies comparing weight-based and pharmacokinetic-model dosing found that weight-based methods were practical and reasonably effective for initiating therapy in patients with venous thromboembolic disease . However, achieving a stable therapeutic aPTT within the first 24 hours remains challenging. One randomized comparison showed that using non-steady-state heparin concentrations to calculate clearance allowed more rapid attainment of an aPTT ratio of at least 1.5 times baseline compared with empiric aPTT-only adjustment . This highlights that the initial calculated rate is a starting point, not a final dose.

Clinical context: why precision matters in this patient

This patient’s pulmonary embolism is hemodynamically significant enough to warrant immediate anticoagulation. The right calf swelling suggests a deep vein thrombosis as the likely source. Combined oral contraceptive use increases thrombin generation and alters fibrinolytic balance, while the 14-hour bus trip caused venous stasis. The goal of the initial heparin infusion is to prevent further thrombus propagation while the body’s endogenous fibrinolytic system begins to dissolve the existing clot. Subtherapeutic heparin during the first 24 hours is associated with a higher risk of recurrent venous thromboembolism, while supratherapeutic levels increase bleeding risk.

Comparison with other anticoagulants

Feature	Unfractionated heparin	Argatroban
Mechanism	Binds antithrombin, inactivates thrombin and factor Xa	Direct thrombin inhibitor, antithrombin-independent
Monitoring	aPTT, affected by biologic variability and heparin resistance	aPTT, more predictable pharmacokinetics
Primary use in this scenario	Initial treatment of acute pulmonary embolism	Alternative when heparin-induced thrombocytopenia is suspected or confirmed
Dosing basis	Weight-based units/kg/h	Fixed or weight-based, organ-dependent

A retrospective cohort study in critically ill patients found that achieving and maintaining therapeutic anticoagulation with unfractionated heparin is difficult due to biologic variability, heparin resistance, and limitations of aPTT monitoring . Argatroban offers more predictable anticoagulation in specific situations, but unfractionated heparin remains the standard initial agent for acute pulmonary embolism because of its rapid onset, reversibility with protamine, and extensive clinical experience.

Key point! The infusion pump is set to 25.2 mL/h. The nurse verifies the patient’s weight, recalculates the dose, confirms the bag concentration, and requests an independent double-check before starting the infusion.